NDAORALSYRUP
Approved
Jan 1952
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
1/8 — Limited
Drug data last refreshed 11h ago · AI intelligence enriched 3w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
PHENERGAN W/ CODEINE is an oral syrup combination product containing codeine phosphate (an opioid analgesic) and promethazine hydrochloride (a phenothiazine antihistamine and antiemetic). It is indicated for cough suppression and relief of upper respiratory symptoms, leveraging codeine's antitussive properties and promethazine's sedating and anti-nausea effects. This product represents a classic combination therapy used primarily in cough management.
LOE Approaching
As a legacy product with LOE approaching, brand team size is likely minimal with focus shifting toward managed decline and generic transition planning.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
Working on PHENERGAN W/ CODEINE offers limited career growth opportunity due to its LOE-approaching status and minimal linked job openings. Career value lies primarily in managing decline, navigating regulatory constraints (particularly around pediatric codeine restrictions), and supporting transition planning—skills useful for portfolio rationalization but not for building visibility through growth.
Brand Manager
Worked on PHENERGAN W/ CODEINE at ANI Pharmaceuticals? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.